Summary: After the introduction of high-throughput sequencing, genotyping arrays continue to be a viable source for conducting large-scale genetic studies. Currently, Illumina is one of the largest genotyping array manufacturers. One technical issue that has always plagued the post-processing of Illumina genotyping array data is the strand definition. Against convention, Illumina uses their own definition of strand, which is inconsistent with the standard reference forward and reverse definition. This issue has been a major obstacle in the consistency of reporting, meta-analysis and correct interpretation of phenotype association results. To date, the strand issue has not been adequately addressed, prompting us to develop StrandScript, a tool that can convert all genotyping data generated from Illumina genotyping arrays to the reference forward strand. StrandScript works independently of the Illumina array version and is future proof for newer Illumina array designs. Furthermore, StrandScript can examine an Illumina genotyping array manifest file and can detect all problematic SNPs, including SNPs with wrong RS ID and SNPs with mismatched probe sequences. Here, we introduce StrandScript's design and development, and demonstrate its effectiveness using real genotyping data.
Introduction
Genotyping microarrays, also known as single nucleotide polymorphism (SNP) arrays, have been the driving force of genome-wide association studies (GWAS) for the last 15 years. The analysis and quality control of Illumina genotyping array have been extensively studied (Guo et al., 2014; Zhao et al., 2017) with the exception of strand consistency (Nelson et al., 2012 (Nelson et al., , 2014 . In GWAS, significant SNPs are always reported as the risk allele (RA), or effective allele. The RA can be presented either on the forward or the reverse strand of the genome. When designing the probes to detect the two alleles of a SNP, the probes can be designed for either the forward or reverse strand. Typically, the reported RA for a SNP will be converted to the forward strand prior to publication. However, strand consistency cannot be inferred confidently, and strand inconsistency often results in the direction of association being wrongly interpreted. This will unnecessarily convolute downstream genetic analyses based on these published SNPs, such as genetic risk scores or Mendelian randomization studies.
The strand of a SNP can be checked by comparing the allele frequency in the dataset with previous reports from an appropriate population database. However, when the allele frequency is near 50%, ambiguity can still arise. Additionally, the strand issue can be resolved by comparing the alleles to a reference genome. Yet, when two alleles of the SNPs are complementary (A/T or C/G), the true strand remains undetermined. The only absolute solution to determine the strand is to compare the probe sequences to a reference Table S1 . On 5 of the 10 arrays, we obtained genotyping data on HapMap (2003) subjects, who were also part of the 1000 Genomes project (1000G) (Abecasis et al., 2012) . We computed the genotype consistency between the genotyping data generated from each array (converted to the forward strand by GenomeStudio and by StrandScript) and from 1000G's released sequencing-based genotyping result.
The overall algorithm for converting the strand designation is depicted in Supplementary Figure S1 . The PLINK file is first screened to remove outdated SNPs (listed as chromosome ¼ 0). The remaining SNPs' probe sequences are checked against the reference sequences. If the number of mismatches is greater than a threshold (default ¼ 20%), that SNP is filtered out and saved in a backup file. If the mismatch count is less than the set threshold, the probe sequence is aligned against the TOP sequence from the manifest file. If that is a match, we do not change the strand designation. If it is not a match, we flip the strand. If the probe sequence has a number of mismatches greater than the threshold, its reverse complementary sequence is then aligned to the reference sequence. If that is a match, we flip the strand, and, if it is not a match, we keep the original strand designation. Since StrandScript does not consider INDELs, all INDELs are left with the original strand designation.
Result
The detailed array statistics can be viewed in Supplementary Tables  S1 and S2 . Using StrandStript, we identified various issues within the manifest files. These issues were summarized in Supplementary Figure S2 . The numbers of mismatched RS ID are listed in Supplementary Table S3 . The second major issue we identified with Illumina manifest files is the mismatch between probe and reference sequences. For the majority of the SNPs, the SNP being tested is at the last position (50%) or the þ 1 position (49%) of the probe sequence (Supplementary Table S4 ). The possible scenarios of SNP position related to the probe sequence, and scenarios of reference mismatches are depicted in Supplementary Figure S2 . Additional examples of mismatched probe sequences are given in Supplementary Figure S3 . Probes are designed to test SNPs on either the forward or reverse strands. The number of SNPs with mismatched percentages between probe sequences and reference sequences for all major Illumina genotyping arrays is listed in Supplementary Table S5 .
To demonstrate the effectiveness of our conversion algorithm, we obtained genotyping data of numerous HapMap control samples on five major Illumina genotyping arrays: the Heart Failure, Human Omni5, Human OmniExpressExome, MEGA EX and Human Exome platforms. These HapMap control samples were also sequenced in the 1000G project and their genotyping data were released in the reference forward strand. We computed the genotype consistencies for both the GenomeStudio forward strand flipped data versus the 1000G released data, and the StrandScript flipped data versus the 1000G released data. The genotype consistency is computed as the number of consistent SNPs between the two datasets divided by the number of overlapping SNPs (SNPs are on the genotyping array and also in 1000G) of the two datasets. The overlap of SNPs between the Illumina genotyping arrays and 1000G ranges from 70.68 to 95.37% of the entire array content. The genotype consistency is a good indication of the data quality for each genotyping platform, assuming the 1000G sequence calls are correct. The genotype consistencies with the 1000G sequencing data computed by the StrandScript forward strand flipped data were consistently higher than the genotype consistencies computed by the standard GenomeStudio forward flipped data (paired t test P ¼ 9.85 Â 10 19 ) (Supplementary Figure S4) . The detailed genotype consistencies can be found in Supplementary Table S6 . The majority of the inconsistent genotypes between the GenomeStudio flipped data and the 1000G data were caused by the strand definition issue. After flipping the strand by StrandScript, the consistencies were nearly 100% for all platforms, with the notable exception of the MEGA EX array. These results provide strong evidence that StrandScript correctly flipped all SNPs to the reference forward strand.
We also compared our tool to the existing approach by Wrayner group (http://www.well.ox.ac.uk/$wrayner/strand/). The result shows that StrandScript performed equal or slightly better under different scenarios (Supplementary Table S7 ). However, the advantage of StrandScript is that it does not require the pre-processed conversion file for each array. It works on all previous and future Illumina genotyping arrays. On the other hand, under the pre-processed approach the users are entirely dependent on the willingness of the author to update their conversion files. For example, in Wrayner group's website, conversion files for the newest 3 out of 10 of the genotyping arrays we tested were not found.
Discussion
Genotyping has been proven to be a practicable alternative to highthroughput sequencing for extensive GWAS. The accumulated GWAS data are valuable resources for meta-analysis, yet metaanalysis critically depends on the correct strand definition across multiple studies and often multiple platforms. Historically, there have been two major genotyping array companies: Illumina and Affymetrix. The designs of the arrays from these two companies are based on different chemistries (LaFramboise, 2009) and have different coverages (Ha et al., 2014; Jiang et al., 2013) . Affymetrix designs all of their genotyping arrays using the reference forward strand. Illumina, on the other hand, adopted an unconventional customized strand definition, which can cause confusion and unnecessarily convoluted downstream analysis (Nelson et al., 2012 (Nelson et al., , 2014 .
Our approach of strand conversion is independent of array version. Instead, it depends on the constancy of the Illumina manifest file designs, which have been consistent over the years. Since it is possible for a SNP to be designed correctly on an array, but the manifest file to contain errors, or vice versa, StrandScript has the ability to examine the Illumina manifest file to identify SNPs with potentially erroneous designs. Although the error rate inside the manifest file for each of the major Illumina genotyping array is only a fraction of the entire design (0.003-0.22%) based on our analysis, the filtering out of these potentially problematic SNPs will increase the overall data integrity. Furthermore, we strongly encourage researchers to include strand orientation when reporting any SNPphenotype associations. The simple inclusion of the strand information will reduce the ambiguity and subsequent labor needed to resolve the confusion, and it will greatly increase the reproducibility of these results and their usability for meta-analysis to construct genetic risk scores.
